1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Patent Number 09861630
US 09861630 B1Filled DateAug 10, 2017
Priority DateJun 16, 2006
Publication DateDec 21, 2017
Expiration DateJun 15, 2026
Inventor/ApplicantsRene Holm
Heidi Lopez de Diego
André Faldt
Andre Faldt
Heidi Lopez de Diego
André Faldt
Andre Faldt
ExaminesPOLANSKY, GREGG
Art Unit1621
Technology Center1600
Assignments
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.